Autosomal dominant polycystic kidney disease

Area of Science:

• Nephrology
• Genetics
• Internal Medicine

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disease and a leading cause of end-stage kidney disease.
• ADPKD is a systemic disorder with diverse clinical manifestations, including enlarged kidneys, hypertension, liver cysts, intracranial aneurysms, and cardiac valvular disease.

Purpose of the Study:

• To review recent advancements in understanding and managing ADPKD.
• To highlight the impact of molecular genetics, advanced imaging, and novel therapeutics on patient care.

Main Methods:

• Review of clinical research, including Phase 3 randomized, placebo-controlled trials.
• Integration of data from molecular genetics and advanced imaging techniques.

Main Results:

• Enhanced diagnostic and prognostic tools are available for ADPKD patients and families.
• A disease-modifying drug is now approved for high-risk ADPKD patients, improving management strategies.

Conclusions:

• Recent developments provide a strong foundation for evidence-based recommendations in ADPKD management.
• Implementing these advances can potentially delay kidney failure, reduce symptoms, and improve cardiovascular outcomes, prolonging life.